NZ548219A - Charcoal stabilization of phenyl phosphates - Google Patents
Charcoal stabilization of phenyl phosphatesInfo
- Publication number
- NZ548219A NZ548219A NZ548219A NZ54821904A NZ548219A NZ 548219 A NZ548219 A NZ 548219A NZ 548219 A NZ548219 A NZ 548219A NZ 54821904 A NZ54821904 A NZ 54821904A NZ 548219 A NZ548219 A NZ 548219A
- Authority
- NZ
- New Zealand
- Prior art keywords
- phenyl phosphate
- charcoal
- solubilized
- phosphate
- amount
- Prior art date
Links
- CMPQUABWPXYYSH-UHFFFAOYSA-N phenyl phosphate Chemical class OP(O)(=O)OC1=CC=CC=C1 CMPQUABWPXYYSH-UHFFFAOYSA-N 0.000 title claims abstract description 311
- 239000003610 charcoal Substances 0.000 title claims abstract description 240
- 230000006641 stabilisation Effects 0.000 title description 5
- 238000011105 stabilization Methods 0.000 title description 5
- 238000002835 absorbance Methods 0.000 claims abstract description 62
- 238000000034 method Methods 0.000 claims abstract description 52
- 230000000694 effects Effects 0.000 claims abstract description 40
- 239000000872 buffer Substances 0.000 claims abstract description 38
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims abstract description 23
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims abstract description 23
- 238000006243 chemical reaction Methods 0.000 claims abstract description 12
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical group OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 claims description 123
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 70
- 230000000087 stabilizing effect Effects 0.000 claims description 50
- 102000004190 Enzymes Human genes 0.000 claims description 48
- 108090000790 Enzymes Proteins 0.000 claims description 48
- 239000000243 solution Substances 0.000 claims description 46
- 239000000758 substrate Substances 0.000 claims description 44
- 238000004064 recycling Methods 0.000 claims description 42
- 230000007071 enzymatic hydrolysis Effects 0.000 claims description 33
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims description 33
- 239000000203 mixture Substances 0.000 claims description 30
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 21
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 21
- 239000003153 chemical reaction reagent Substances 0.000 claims description 17
- 102000013563 Acid Phosphatase Human genes 0.000 claims description 15
- 108010051457 Acid Phosphatase Proteins 0.000 claims description 15
- 239000008366 buffered solution Substances 0.000 claims description 12
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 claims description 11
- 229910019142 PO4 Inorganic materials 0.000 claims description 11
- 230000007062 hydrolysis Effects 0.000 claims description 10
- 238000006460 hydrolysis reaction Methods 0.000 claims description 10
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 10
- 239000008188 pellet Substances 0.000 claims description 9
- 239000010452 phosphate Substances 0.000 claims description 9
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 claims description 8
- 238000001952 enzyme assay Methods 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- 239000007983 Tris buffer Substances 0.000 claims description 7
- 150000002681 magnesium compounds Chemical class 0.000 claims description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical class [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 238000007789 sealing Methods 0.000 claims description 3
- 230000003381 solubilizing effect Effects 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- UXFQFBNBSPQBJW-UHFFFAOYSA-N 2-amino-2-methylpropane-1,3-diol Chemical compound OCC(N)(C)CO UXFQFBNBSPQBJW-UHFFFAOYSA-N 0.000 claims description 2
- 238000012986 modification Methods 0.000 claims description 2
- 230000004048 modification Effects 0.000 claims description 2
- 101150035093 AMPD gene Proteins 0.000 claims 1
- 230000003019 stabilising effect Effects 0.000 abstract 3
- 238000003860 storage Methods 0.000 description 18
- 238000003556 assay Methods 0.000 description 15
- VLTINPRVNHVFLH-UHFFFAOYSA-N 3-amino-2-methylprop-1-ene-1,1-diol Chemical compound NCC(C)=C(O)O VLTINPRVNHVFLH-UHFFFAOYSA-N 0.000 description 13
- 238000011282 treatment Methods 0.000 description 12
- 239000000523 sample Substances 0.000 description 11
- 235000021317 phosphate Nutrition 0.000 description 9
- 229910052799 carbon Inorganic materials 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 230000007774 longterm Effects 0.000 description 7
- -1 PNPP Chemical class 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 5
- 238000000502 dialysis Methods 0.000 description 5
- 238000007824 enzymatic assay Methods 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 description 4
- 229920002274 Nalgene Polymers 0.000 description 4
- 239000012491 analyte Substances 0.000 description 4
- 239000007795 chemical reaction product Substances 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 238000005057 refrigeration Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 102000004157 Hydrolases Human genes 0.000 description 3
- 108090000604 Hydrolases Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- FSVCELGFZIQNCK-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)glycine Chemical compound OCCN(CCO)CC(O)=O FSVCELGFZIQNCK-UHFFFAOYSA-N 0.000 description 3
- MKWKNSIESPFAQN-UHFFFAOYSA-N N-cyclohexyl-2-aminoethanesulfonic acid Chemical compound OS(=O)(=O)CCNC1CCCCC1 MKWKNSIESPFAQN-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000003929 acidic solution Substances 0.000 description 3
- 229960002319 barbital Drugs 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 3
- 229910001425 magnesium ion Inorganic materials 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical class OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- CPBJMKMKNCRKQB-UHFFFAOYSA-N 3,3-bis(4-hydroxy-3-methylphenyl)-2-benzofuran-1-one Chemical compound C1=C(O)C(C)=CC(C2(C3=CC=CC=C3C(=O)O2)C=2C=C(C)C(O)=CC=2)=C1 CPBJMKMKNCRKQB-UHFFFAOYSA-N 0.000 description 2
- HSHNITRMYYLLCV-UHFFFAOYSA-N 4-methylumbelliferone Chemical compound C1=C(O)C=CC2=C1OC(=O)C=C2C HSHNITRMYYLLCV-UHFFFAOYSA-N 0.000 description 2
- 239000008000 CHES buffer Substances 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 108010008488 Glycylglycine Proteins 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- 239000007993 MOPS buffer Substances 0.000 description 2
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical class CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- UZMAPBJVXOGOFT-UHFFFAOYSA-N Syringetin Natural products COC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UZMAPBJVXOGOFT-UHFFFAOYSA-N 0.000 description 2
- 239000007994 TES buffer Substances 0.000 description 2
- 239000007997 Tricine buffer Substances 0.000 description 2
- 238000010306 acid treatment Methods 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000003637 basic solution Substances 0.000 description 2
- 239000007998 bicine buffer Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000007398 colorimetric assay Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000003366 endpoint assay Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 229960002449 glycine Drugs 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 125000000962 organic group Chemical group 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000001223 reverse osmosis Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical compound C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 1
- VTYBYCXLGOZQPN-UHFFFAOYSA-N 2-(2-aminoethyl)propane-1,3-diol Chemical class NCCC(CO)CO VTYBYCXLGOZQPN-UHFFFAOYSA-N 0.000 description 1
- YHBAZQDEMYQPJL-UHFFFAOYSA-N 2-[(2-aminoacetyl)amino]acetic acid;hydron;chloride Chemical compound Cl.NCC(=O)NCC(O)=O YHBAZQDEMYQPJL-UHFFFAOYSA-N 0.000 description 1
- DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 description 1
- BTJIUGUIPKRLHP-UHFFFAOYSA-M 4-nitrophenolate Chemical compound [O-]C1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-M 0.000 description 1
- XZKIHKMTEMTJQX-UHFFFAOYSA-L 4-nitrophenyl phosphate(2-) Chemical compound [O-][N+](=O)C1=CC=C(OP([O-])([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-L 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 239000008001 CAPS buffer Substances 0.000 description 1
- 101100283604 Caenorhabditis elegans pigk-1 gene Proteins 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical class C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 1
- JOCBASBOOFNAJA-UHFFFAOYSA-N N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid Chemical compound OCC(CO)(CO)NCCS(O)(=O)=O JOCBASBOOFNAJA-UHFFFAOYSA-N 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 238000011111 UV-scan method Methods 0.000 description 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000004855 amber Substances 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000002967 competitive immunoassay Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940043257 glycylglycine Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 125000001841 imino group Chemical group [H]N=* 0.000 description 1
- 238000001114 immunoprecipitation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 239000011777 magnesium Chemical class 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-M phenolate Chemical compound [O-]C1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-M 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000002901 radioactive waste Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- CIJQGPVMMRXSQW-UHFFFAOYSA-M sodium;2-aminoacetic acid;hydroxide Chemical compound O.[Na+].NCC([O-])=O CIJQGPVMMRXSQW-UHFFFAOYSA-M 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011232 storage material Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3834—Aromatic acids (P-C aromatic linkage)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/23—Carbon containing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/23—Carbon containing
- Y10T436/235—In an aqueous solution [e.g., TOC, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/2525—Stabilizing or preserving
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Sampling And Sample Adjustment (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/727,537 US7001717B2 (en) | 2003-12-05 | 2003-12-05 | Charcoal stabilization of phenyl phosphates |
| PCT/US2004/040177 WO2005056816A1 (en) | 2003-12-05 | 2004-12-02 | Charcoal stabilization of phenyl phosphates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ548219A true NZ548219A (en) | 2009-02-28 |
Family
ID=34633507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ548219A NZ548219A (en) | 2003-12-05 | 2004-12-02 | Charcoal stabilization of phenyl phosphates |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7001717B2 (https=) |
| EP (1) | EP1709186B1 (https=) |
| JP (2) | JP4620061B2 (https=) |
| AU (1) | AU2004297569A1 (https=) |
| CA (1) | CA2548530C (https=) |
| NZ (1) | NZ548219A (https=) |
| WO (1) | WO2005056816A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220064861A (ko) * | 2019-09-17 | 2022-05-19 | 노바 바이오메디컬 코포레이션 | 혈액 중 간 효소 수준을 측정하기 위한 시스템 및 방법 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1958210A (en) | 1932-07-01 | 1934-05-08 | Kavalco Products Inc | Method of making aryl phosphates and product thereof |
| US3951859A (en) | 1972-12-30 | 1976-04-20 | Toyo Jozo Co., Ltd. | Molecular sieving particle and preparation thereof |
| DE2341294C3 (de) | 1973-08-16 | 1981-12-24 | Bayer Ag, 5090 Leverkusen | Polyolgemische |
| US4042335A (en) | 1975-07-23 | 1977-08-16 | Eastman Kodak Company | Integral element for analysis of liquids |
| US4157280A (en) | 1975-09-29 | 1979-06-05 | Cordis Corporation | Test set for detecting the presence of antigens associated with hepatitis |
| US4028465A (en) | 1975-11-10 | 1977-06-07 | Bio-Rad Laboratories | Assay method for serum folate |
| US4372874A (en) | 1976-09-13 | 1983-02-08 | Modrovich Ivan Endre | Stabilization of hydrolysis prone labile organic reagents in liquid media |
| US4132598A (en) | 1977-06-03 | 1979-01-02 | Modrovich Ivan Endre | Stabilized liquid phosphate containing diagnostic compositions and method of preparing same |
| US4594249A (en) | 1985-06-14 | 1986-06-10 | 21St Century Marketing, Inc. | Method of altering intoxicating effects of alcohol |
| JPH0379601A (ja) * | 1989-03-24 | 1991-04-04 | Shinkoujin Kasei Kk | 高機能性再生セルロース組成物 |
| US5508182A (en) * | 1991-02-13 | 1996-04-16 | Schneider; Manfred P. | Esterification of hydrophilic polyols by adsorption onto a solid support and employing a substrate-immiscible solvent |
| BE1006432A3 (fr) * | 1992-12-02 | 1994-08-23 | Solvay | Procede de purification de 1,1-difluoroethane. |
| GB9422991D0 (en) * | 1994-11-15 | 1995-01-04 | Cortecs Ltd | Analytical method |
| US5464560A (en) | 1995-04-06 | 1995-11-07 | Bayer Corporation | Foam-forming mixtures with decreased decomposition of hydrohalocarbon blowing agents |
| US6177599B1 (en) * | 1995-11-17 | 2001-01-23 | Oxy Vinyls, L.P. | Method for reducing formation of polychlorinated aromatic compounds during oxychlorination of C1-C3 hydrocarbons |
| US5750812A (en) * | 1995-12-28 | 1998-05-12 | The Geon Company | Method for reducing formation of polychlorinated aromatic compounds during air oxychlorination of C1 -C3 Hydrocarbons |
| EP0816514B1 (en) | 1996-06-24 | 2003-04-09 | Tosoh Corporation | Enzyme substrate |
| DE19632432A1 (de) | 1996-08-12 | 1998-02-19 | Boehringer Mannheim Gmbh | Stabile Mischung zum Nachweis alkalischer Phosphatase mit einem Salz der o-Kresolphthaleinmonophosphorsäure |
| JP3677432B2 (ja) * | 2000-04-13 | 2005-08-03 | 松下電器産業株式会社 | 電気湯沸かし器 |
| US6887714B2 (en) | 2000-10-16 | 2005-05-03 | Board Of Trustees Of The University Of Arkansas, N.A. | Microvolume immunoabsorbant assays with amplified electrochemical detection |
-
2003
- 2003-12-05 US US10/727,537 patent/US7001717B2/en not_active Expired - Lifetime
-
2004
- 2004-12-02 EP EP04812640.3A patent/EP1709186B1/en not_active Expired - Lifetime
- 2004-12-02 WO PCT/US2004/040177 patent/WO2005056816A1/en not_active Ceased
- 2004-12-02 NZ NZ548219A patent/NZ548219A/en unknown
- 2004-12-02 JP JP2006542699A patent/JP4620061B2/ja not_active Expired - Fee Related
- 2004-12-02 AU AU2004297569A patent/AU2004297569A1/en not_active Abandoned
- 2004-12-02 CA CA2548530A patent/CA2548530C/en not_active Expired - Lifetime
-
2005
- 2005-11-01 US US11/262,715 patent/US7214481B2/en not_active Expired - Fee Related
-
2010
- 2010-03-29 JP JP2010075380A patent/JP4620172B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010187684A (ja) | 2010-09-02 |
| AU2004297569A1 (en) | 2005-06-23 |
| WO2005056816A1 (en) | 2005-06-23 |
| EP1709186B1 (en) | 2013-04-24 |
| CA2548530C (en) | 2014-08-12 |
| US20050124024A1 (en) | 2005-06-09 |
| JP4620061B2 (ja) | 2011-01-26 |
| JP2007512843A (ja) | 2007-05-24 |
| US20060063220A1 (en) | 2006-03-23 |
| US7001717B2 (en) | 2006-02-21 |
| EP1709186A1 (en) | 2006-10-11 |
| JP4620172B2 (ja) | 2011-01-26 |
| EP1709186A4 (en) | 2009-01-14 |
| CA2548530A1 (en) | 2005-06-23 |
| US7214481B2 (en) | 2007-05-08 |
| HK1099565A1 (en) | 2007-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Melchior Jr et al. | Ethoxyformylation of proteins. Reaction of ethoxyformic anhydride with. alpha.-chymotrypsin, pepsin, and pancreatic ribonuclease at pH 4 | |
| Penney | A simple micro-assay for inorganic phosphate | |
| US3413198A (en) | Reagents and method for assaying biological samples | |
| US4372874A (en) | Stabilization of hydrolysis prone labile organic reagents in liquid media | |
| IE83874B1 (en) | Use of crosslinked crystals as a novel form of enzyme immobilization | |
| CA2848743A1 (en) | Customized quality controls for analytical assays | |
| JPS62118887A (ja) | クレアチンキナーゼ用対照及び標準血清の製法及び該血清 | |
| WO2010105820A1 (en) | Improved blends containing proteases | |
| CN115993460B (zh) | 一种碱性磷酸酶标记肌红蛋白抗体稀释液及其制备方法 | |
| CA2548530C (en) | Charcoal stabilization of phenyl phosphates | |
| US4132598A (en) | Stabilized liquid phosphate containing diagnostic compositions and method of preparing same | |
| Gantzer et al. | Characterization of Mg2+-ATPase from sheep kidney medulla: purification | |
| WO2018136082A1 (en) | Thermostabile beta-glucuronidase formulations | |
| HK1099565B (en) | Charcoal stabilization of phenyl phosphates | |
| CA1132034A (en) | Stabilization of hydrolysis prone labile organic reagents in liquid media | |
| Soru | Chemical and immunological properties of B. anthracis arginase and its metabolic involvement | |
| US3546074A (en) | Reagent for assaying glutamate oxaloacetate transaminase | |
| US3527331A (en) | Reagent for assaying aldolase | |
| JP2003043035A (ja) | 液状試薬原料の製造方法および組成物 | |
| Huang et al. | d-Serine Dehydratase from Escherichia coli: IV. COMPARATIVE SEQUENCES OF PYRIDOXYLPEPTIDES DERIVED FROM THE ACTIVE SITE AND FROM AN INHIBITORY SITE OF THE ENZYME | |
| GB2065881A (en) | Lipase determination method and reagent | |
| US3527332A (en) | Method for assaying glutamate pyruvate transaminase | |
| JPH07229902A (ja) | ヘモグロビンの安定化方法 | |
| JP2003066040A (ja) | 液状試薬原料の製造方法および組成物 | |
| JPH1175896A (ja) | タンパク質分解酵素阻害物質の測定方法およびそれに用いる測定キット |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed |